SMAD7 and Hepatic fibrosis: In our present study, we found that miR-497 facilitated the TGF-β/Smad signaling pathway by targeting Smad7, which promoted the activation of HSCs and exacerbated liver fibrosis in vivo and in vitro, respectively.